Inflection Biosciences and AUM Biosciences Announce Global License Agreement for PIM/PI3K/mTOR Inhibitors
ADTRAN, Inc. Reports Preliminary Earnings for the Second Quarter 2019 and Declares Quarterly Cash Dividend
Avisto Capital Partners Acquires Second Back Office Support Firm Launching Start of Nationwide Solution for E&P Sector